Non-linear association of fasting C-peptide and uric acid levels with renal dysfunction based on restricted cubic spline in patients with type 2 diabetes: A real-world study

被引:8
作者
Chen, Lu [1 ]
Hu, Yifei [1 ]
Ma, Yongjun [1 ]
Wang, Huabin [1 ,2 ]
机构
[1] Zhejiang Univ, Affiliated Jinhua Hosp, Dept Clin Lab, Sch Med, Jinhua, Zhejiang, Peoples R China
[2] Zhejiang Univ, Affiliated Jinhua Hosp, Cent Lab, Sch Med, Jinhua, Zhejiang, Peoples R China
关键词
C-peptide; non-linear association; renal dysfunction; type; 2; diabetes; uric acid; POST-HOC ANALYSIS; RISK; VARIABILITY; OUTCOMES;
D O I
10.3389/fendo.2023.1157123
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundPrevious studies had showed divergent findings on the associations of C-peptide and/or uric acid (UA) with renal dysfunction odds in patients with type 2 diabetes mellitus (T2DM). We hypothesized that there were non-linear relationships between C-peptide, UA and renal dysfunction odds. This study aimed to further investigate the relationships of different stratification of C-peptide and UA with renal dysfunction in patients with T2DM. MethodWe conducted a cross-sectional real-world observational study of 411 patients with T2DM. The levels of fasting C-peptide, 2h postprandial C-peptide, the ratio of fasting C-peptide to 2h postprandial C-peptide (C0/C2 ratio), UA and other characteristics were recorded. Restricted cubic spline (RCS) curves was performed to evaluated the associations of stratified C-peptide and UA with renal dysfunction odds. ResultsFasting C-peptide, C0/C2 ratio and UA were independently and significantly associated with renal dysfunction in patients with T2DM as assessed by multivariate analyses (p < 0.05). In especial, non-linear relationships with threshold effects were observed among fasting C-peptide, UA and renal dysfunction according to RCS analyses. Compared with patients with 0.28 <= fasting C-peptide <= 0.56 nmol/L, patients with fasting C-peptide < 0.28 nmol/L (OR = 1.38, p = 0.246) or fasting C-peptide > 0.56 nmol/L (OR = 1.85, p = 0.021) had relatively higher renal dysfunction odds after adjusting for confounding factors. Similarly, compared with patients with 276 <= UA <= 409 mu mol/L, patients with UA < 276 mu mol/L (OR = 1.32, p = 0.262) or UA > 409 mu mol/L (OR = 6.24, p < 0.001) had relatively higher odds of renal dysfunction. ConclusionThe renal dysfunction odds in patients with T2DM was non-linearly associated with the levels of serum fasting C-peptide and UA. Fasting C-peptide and UA might have the potential role in odds stratification of renal dysfunction.
引用
收藏
页数:8
相关论文
共 32 条
[1]   Selecting the number of categories of the lymph node ratio in cancer research: A bootstrap-based hypothesis test [J].
Barrio, Irantzu ;
Roca-Pardinas, Javier ;
Arostegui, Inmaculada .
STATISTICAL METHODS IN MEDICAL RESEARCH, 2021, 30 (03) :926-940
[2]   A new approach to categorising continuous variables in prediction models: Proposal and validation [J].
Barrio, Irantzu ;
Arostegui, Inmaculada ;
Rodriguez-Alvarez, Maria-Xose ;
Quintana, Jose-Maria .
STATISTICAL METHODS IN MEDICAL RESEARCH, 2017, 26 (06) :2586-2602
[3]   Variability in HbA1c, blood pressure, lipid parameters and serum uric acid, and risk of development of chronic kidney disease in type 2 diabetes [J].
Ceriello, Antonio ;
De Cosmo, Salvatore ;
Rossi, Maria Chiara ;
Lucisano, Giuseppe ;
Genovese, Stefano ;
Pontremoli, Roberto ;
Fioretto, Paola ;
Giorda, Carlo ;
Pacilli, Antonio ;
Viazzi, Francesca ;
Russo, Giuseppina ;
Nicolucci, Antonio .
DIABETES OBESITY & METABOLISM, 2017, 19 (11) :1570-1578
[4]   Derivation and validation of a machine learning risk score using biomarker and electronic patient data to predict progression of diabetic kidney disease [J].
Chan, Lili ;
Nadkarni, Girish N. ;
Fleming, Fergus ;
McCullough, James R. ;
Connolly, Patricia ;
Mosoyan, Gohar ;
El Salem, Fadi ;
Kattan, Michael W. ;
Vassalotti, Joseph A. ;
Murphy, Barbara ;
Donovan, Michael J. ;
Coca, Steven G. ;
Damrauer, Scott M. .
DIABETOLOGIA, 2021, 64 (07) :1504-1515
[5]   Significant association of urinary alpha-1-microglobulin compared to urinary neutrophil gelatinase-associated lipocalin with renal insufficiency in patients with type 2 diabetes [J].
Chen, Guangming ;
Shan, Xiaoyun ;
Wang, Huabin .
NEPHROLOGY, 2021, 26 (05) :400-407
[6]   Baseline risk markers and visit-to-visit variability in relation to kidney outcomes - A post-hoc analysis of the PERL study* [J].
Curovic, Viktor Rotbain ;
Roy, Neil ;
Hansen, Tine W. ;
Caramori, M. Luiza ;
Cherney, David Z. ;
Boer, Ian H. De ;
Emanuele, Mary Ann ;
Emanuele, Ian Ann ;
Hirsch, Irl B. ;
Lingvay, Ildiko ;
Mcgill, Janet B. ;
Polsky, Sarit ;
Pop-Busui, Rodica ;
Sigal, Ronald J. ;
Tuttle, Katherine R. ;
Umpierrez, Guillermo E. ;
Wallia, Amisha ;
Rosas, Sylvia E. ;
Rossing, Peter .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 193
[7]   Serum Uric Acid and Risk of CKD in Type 2 Diabetes [J].
De Cosmo, Salvatore ;
Viazzi, Francesca ;
Pacilli, Antonio ;
Giorda, Carlo ;
Ceriello, Antonio ;
Gentile, Sandro ;
Russo, Giuseppina ;
Rossi, Maria C. ;
Nicolucci, Antonio ;
Guida, Pietro ;
Feig, Daniel ;
Johnson, Richard J. ;
Pontremoli, Roberto .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 10 (11) :1921-1929
[8]   Effects of SGLT2 inhibitors on patients with diabetic kidney disease: A preliminary study on the basis of podocyturia [J].
Durcan, Emre ;
Ozkan, Serbay ;
Saygi, Halil Ibrahim ;
Dincer, Mevlut Tamer ;
Korkmaz, Ozge Polat ;
Sahin, Serdar ;
Karaca, Cebrail ;
Sulu, Cem ;
Bakir, Alev ;
Ozkaya, Hande Mefkure ;
Trabulus, Sinan ;
Guzel, Elif ;
Seyahi, Nurhan ;
Gonen, Mustafa Sait .
JOURNAL OF DIABETES, 2022, 14 (04) :236-246
[9]   C-Peptide as a Therapeutic Tool in Diabetic Nephropathy [J].
Hills, Claire E. ;
Brunskill, Nigel J. ;
Squires, Paul E. .
AMERICAN JOURNAL OF NEPHROLOGY, 2010, 31 (05) :389-397
[10]   Cellular and physiological effects of C-peptide [J].
Hills, Claire E. ;
Brunskill, Nigel J. .
CLINICAL SCIENCE, 2009, 116 (7-8) :565-574